PMDA — authorised 26 September 2022
- Marketing authorisation holder: ALNYLAM JAPAN, K.K
- Status: approved
🇯🇵 Amvuttra in Japan
PMDA authorised Amvuttra on 26 September 2022
Marketing authorisation
Amvuttra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Japan
Frequently asked questions
Is Amvuttra approved in Japan?
Yes. PMDA authorised it on 26 September 2022.
Who is the marketing authorisation holder for Amvuttra in Japan?
ALNYLAM JAPAN, K.K holds the Japanese marketing authorisation.